Rofecoxib, a COX-2 Inhibitor, Lowers C-Reactive Protein and Interleukin-6 Levels in Patients With Acute Coronary Syndromes

Chest - United States
doi 10.1378/chest.125.5.1610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

C Reactive Protein for Risk Stratification in Acute Coronary Syndromes? Verdict: Unproven

Heart
2003English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Association Between Serum Levels of High Sensitivity C-Reactive Protein, Interleukin-1 and Interleukin-6 With Pain Intensity in Patients With Low Back Pain Without Sciatica

Open Access Macedonian Journal of Medical Sciences
Medicine
2020English

Serum Level of Interleukin-33, C-Reactive Protein, and Troponin in Iraqi Coronary Artery Disease Patients

Iraqi Journal of Science
GeneticsMolecular BiologyGeologyBiochemistryComputer ScienceBiotechnologyChemistry
2020English

Prognostic Role of C-Reactive Protein and Interleukin-6 in Dialysis Patients: A Systematic Review and Meta-Analysis

Journal of Nephrology
Nephrology
2012English

Interleukin-6 and C-Reactive Protein as Early Markers of Sepsis in Patients With Diabetic Ketoacidosis or Hyperosmosis

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2001English

Mechanisms of C-Reactive Protein, Interleukin-6 and Soluble CD40L Blood Concentration Changes After Coronary Stent Implantation

World Journal of Cardiovascular Diseases
2012English

Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Prognostic Significance of Angiogenic Growth Factor Serum Levels in Patients With Acute Coronary Syndromes

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy